Literature DB >> 20636342

Quality control of fifteen probiotic products containing Saccharomyces boulardii.

L M E Vanhee1, F Goemé, H J Nelis, T Coenye.   

Abstract

AIMS: The yeast Saccharomyces boulardii is used as a probiotic for the prevention and treatment of diarrhoea. In this study, the quality of 15 probiotic products containing S. boulardii was verified. METHODS AND
RESULTS: Using microsatellite typing, the identity of all Saccharomyces strains in the products was confirmed as S. boulardii. Additionally, solid-phase cytometry (SPC) and a plate method were used to enumerate S. boulardii cells. SPC was not only able to produce results more rapidly than plating (4h compared to 48h) but the cell counts obtained with SPC were significantly higher than the plate counts. Finally, we found that <1% of the S. boulardii cells survived 120min in gastric conditions and storage for 3months at 40°C with 75% relative humidity.
CONCLUSIONS: We developed a SPC method for the quantification of viable S. boulardii cells in probiotics. Additionally, we demonstrated that gastric conditions and storage have a marked effect on the viability of the yeast cells. SIGNIFICANCE AND IMPACT OF THE STUDY: To our knowledge, this is the first time SPC is used for the quality control of probiotics with S. boulardii. Additionally, we demonstrated the need for gastric protection and accurate storage.
© 2010 The Authors. Journal of Applied Microbiology © 2010 The Society for Applied Microbiology.

Entities:  

Mesh:

Year:  2010        PMID: 20636342     DOI: 10.1111/j.1365-2672.2010.04805.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  6 in total

1.  A double blind randomized trial showing probiotics to be ineffective in acute diarrhea in Indonesian children.

Authors:  Badriul Hegar; I Made Indra Waspada; Hartono Gunardi; Yvan Vandenplas
Journal:  Indian J Pediatr       Date:  2014-04-29       Impact factor: 1.967

2.  Probiotics and prebiotics in infants and children.

Authors:  Y Vandenplas; E De Greef; T Devreker; G Veereman-Wauters; B Hauser
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

3.  Quantification of Pseudomonas aeruginosa in multispecies biofilms using PMA-qPCR.

Authors:  Sarah Tavernier; Tom Coenye
Journal:  PeerJ       Date:  2015-02-24       Impact factor: 2.984

4.  Choosing an appropriate probiotic product for your patient: An evidence-based practical guide.

Authors:  Jason C Sniffen; Lynne V McFarland; Charlesnika T Evans; Ellie J C Goldstein
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240

Review 5.  Probiotics and Amelioration of Rheumatoid Arthritis: Significant Roles of Lactobacillus casei and Lactobacillus acidophilus.

Authors:  Alok K Paul; Anita Paul; Rownak Jahan; Khoshnur Jannat; Tohmina A Bondhon; Anamul Hasan; Veeranoot Nissapatorn; Maria L Pereira; Polrat Wilairatana; Mohammed Rahmatullah
Journal:  Microorganisms       Date:  2021-05-16

Review 6.  Contrasting Strategies: Human Eukaryotic Versus Bacterial Microbiome Research.

Authors:  Katarzyna B Hooks; Maureen A O'Malley
Journal:  J Eukaryot Microbiol       Date:  2019-10-20       Impact factor: 3.346

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.